Condition
Critical Illness Polyneuromyopathy
Total Trials
6
Recruiting
2
Active
2
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07478367RecruitingPrimary
Critical Illness Weakness Outside the Intensive Care Unit.
NCT06419699Recruiting
CPAx: Responsiveness and Minimal Clinically Important Difference
NCT04423796Not ApplicableCompletedPrimary
Robotic Assisted Early Mobilization in Ventilated ICU Patients
NCT04750265Not ApplicableCompleted
Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19
NCT04435080Completed
Physical Rehabilitation in ICU in ARDS Patients With COVID-19
NCT04227548Not ApplicableCompletedPrimary
Reference Values for Compound Muscle Action Potential Amplitude Obtained by Direct Muscle Stimulation
Showing all 6 trials